Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis

키워드

참고문헌 (54)

1. Sanjay Vasant Kamble, "Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?", The Korean Journal of Pain, 30(3), pp.183~191 (2017), 대한통증학회
2. Werhagen L, "Neuropathic pain after traumatic spinal cord injury--relations to gender, spinal level, completeness, and age at the time of injury", Spinal Cord, 42, pp.665~673 (2004)
3. Castro MM, "Sleep patterns and symptoms of anxiety and depression in patients with chronic pain", Arq Neuropsiquiatr, 67, pp.25~28 (2009)
4. Gore M, "Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep", J Pain Symptom Manage, 30, pp.374~385 (2005)
5. Gormsen L, "Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain", Eur J Pain, 14, pp.127.e1~8 (2010)
6. McDermott AM, "The burden of neuropathic pain : results from a cross-sectional survey", Eur J Pain, 10, pp.127~135 (2006)
7. Gustorff B, "Prevalence of self-reported neuropathic pain and impact on quality of life : a prospective representative survey", Acta Anaesthesiol Scand, 52, pp.132~136 (2008)
8. Vafa Rahimi-Movaghar, "Evaluation of Pain and Its Effect on Quality of Life and Functioning in Men with Spinal Cord Injury", The Korean Journal of Pain, 28(2), pp.129~136 (2015), 대한통증학회
9. Lude P, "Quality of life in and after spinal cord injury rehabilitation : a longitudinal multicenter study", Top Spinal Cord Inj Rehabil, 20, pp.197~207 (2014)
10. Dermanovic Dobrota V, "The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes", Health Qual Life Outcomes, 12, pp.171~ (2014)
11. Geyh S, "Quality of life after spinal cord injury : a comparison across six countries", Spinal Cord, 51, pp.322~326 (2013)
12. Yeon Ju Leem, "Central Pain from Excitotoxic Spinal Cord Injury Induced by Intraspinal NMDA Injection: A Pilot Study", The Korean Journal of Pain, 23(2), pp.109~115 (2010), 대한통증학회
13. Wollaars MM, "Spinal cord injury pain : the influence of psychologic factors and impact on quality of life", Clin J Pain, 23, pp.383~391 (2007)
14. Smith BH, "Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community", Clin J Pain, 23, pp.143~149 (2007)
15. Gálvez R, "Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions", Eur J Pain, 11, pp.244~255 (2007)
16. Davies M, "The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes", Diabetes Care, 29, pp.1518~1522 (2006)
17. Teasell RW, "A systematic review of pharmacologic treatments of pain after spinal cord injury", Arch Phys Med Rehabil, 91, pp.816~831 (2010)
18. DeFrates S, "Pharmacologic treatment of neuropathic pain following spinal cord injury", Orthopedics, 34, pp.203~ (2011)
19. Hagen EM, "Management of neuropathic pain associated with spinal cord injury", Pain Ther, 4, pp.51~65 (2015)
20. Rowbotham M, "Gabapentin for the treatment of postherpetic neuralgia : a randomized controlled trial", JAMA, 280, pp.1837~1842 (1998)
21. Rice AS, "Gabapentin in postherpetic neuralgia : a randomised, double blind, placebo controlled study", Pain, 94, pp.215~224 (2001)
22. Sabatowski R, "Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia : results of a randomised, placebo-controlled clinical trial", Pain, 109, pp.26~35 (2004)
23. van Seventer R, "Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia : a 13-week, randomized trial", Curr Med Res Opin, 22, pp.375~384 (2006)
24. Moon DE, "Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain : a 10-week, randomized, double-blind, placebo-controlled, multicenter study", Clin Ther, 32, pp.2370~2385 (2010)
25. Xochilcal-Morales M, "A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America", Int J Clin Pract, 64, pp.1301~1309 (2010)
26. Guan Y, "Efficacy of pregabalin for peripheral neuropathic pain : results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China", Clin Ther, 33, pp.159~166 (2011)
27. Backonja M, "Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus : a randomized controlled trial", JAMA, 280, pp.1831~1836 (1998)
28. Sandercock D, "Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy : efficacy and tolerability in a double-blind, randomized, controlled clinical trial", Diabetes Care, 32, pp.e20~ (2009)
29. Tölle T, "Pregabalin for relief of neuropathic pain associated with diabetic neuropathy : a randomized, double-blind study", Eur J Pain, 12, pp.203~213 (2008)
30. Guay DR, "Pregabalin in neuropathic pain: a more “pharmaceutically elegant” gabapentin?", Am J Geriatr Pharmacother, 3, pp.274~287 (2005)
31. Turner JA, "Chronic pain associated with spinal cord injuries : a community survey", Arch Phys Med Rehabil, 82, pp.501~509 (2001)
32. Tzellos TG, "Efficacy of pregabalin and gabapentin for neuropathic pain in spinalcord injury : an evidence-based evaluation of the literature", Eur J Clin Pharmacol, 64, pp.851~858 (2008)
33. Attal N, "Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)", Ann Phys Rehabil Med, 52, pp.124~141 (2009)
34. Snedecor SJ, "Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury", J Pain Res, 6, pp.539~547 (2013)
35. Guy S, "Anticonvulsant medication use for the management of pain following spinal cord injury : systematic review and effectiveness analysis", Spinal Cord, 52, pp.89~96 (2014)
36. Mehta S, "Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury : a metaanalysis", Arch Phys Med Rehabil, 95, pp.2180~2186 (2014)
37. Song F, "Validity of indirect comparison for estimating efficacy of competing interventions : empirical evidence from published meta-analyses", BMJ, 326, pp.472~ (2003)
38. Moher D, "Preferred reporting items for systematic reviews and metaanalyses : the PRISMA statement", Ann Intern Med, 151, pp.264~269 (2009)
39. Tai Q, "Gabapentin in the treatment of neuropathic pain after spinal cord injury : a prospective, randomized, double-blind, crossover trial", J Spinal Cord Med, 25, pp.100~105 (2002)
40. Levendoglu F, "Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury", Spine (Phila Pa 1976), 29, pp.743~751 (2004)
41. Siddall PJ, "Pregabalin in central neuropathic pain associated with spinal cord injury : a placebo-controlled trial", Neurology, 67, pp.1792~1800 (2006)
42. Rintala DH, "Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury", Arch Phys Med Rehabil, 88, pp.1547~1560 (2007)
43. Vranken JH, "Pregabalin in patients with central neuropathic pain : a randomized, double-blind, placebocontrolled trial of a flexible-dose regimen", Pain, 136, pp.150~157 (2008)
44. Cardenas DD, "A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury", Neurology, 80, pp.533~539 (2013)
45. Kaydok E, "Comparison of the efficacy of gabapentin and pregabalin for neuropathic pain in patients with spinal cord injury : a crossover study", Acta Med Mediterranea, 30, pp.1343~ (2014)
46. Yilmaz B, "pregabalin for the treatment of neuropathic pain in patients with spinal cord injury : a crossover study", Turk J Phys Med Rehab, 61, pp.1~5 (2014)
47. Ghosh AK, "Comparative study of efficacy and safety of pregabalin and gabapentin in neuropathic pain", Asian J Pharm Life Sci, 2, pp.64~71 (2012)
48. Donegan S, "Indirect comparisons : a review of reporting and methodological quality", PLoS One, 5, pp.e11054~ (2010)
49. Dworkin RH, "Pharmacologic management of neuropathic pain : evidence-based recommendations", Pain, 132, pp.237~251 (2007)
50. Putzke JD, "Longterm use of gabapentin for treatment of pain after traumatic spinal cord injury", Clin J Pain, 18, pp.116~121 (2002)
51. To TP, "Gabapentin for neuropathic pain following spinal cord injury", Spinal Cord, 40, pp.282~285 (2002)
52. Ahn SH, "Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms", Spine (Phila Pa 1976), 28, pp.341~346 (2003)
53. Song F, "Methodological problems in the use of indirect comparisons for evaluating healthcare interventions : survey of published systematic reviews", BMJ, 338, pp.b1147~ (2009)
54. Onouchi K, "An openlabel, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain", J Pain Res, 7, pp.439~447 (2014)

관련 논문AI추천